Sun Pharmaceuticals reported 20.75B in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Aspen Pharmacare APN:SJ 428.7B 424.18B
Bharat Petroleum BPCL:IN 6.28B 2.96B
Cipla CIPLA:IN 9.56B 633.3M
Dr.Reddys Laboratories DRRD:IN 23.8B 38M
Jiangsu Hengrui Me. 600276:CH 1.95B 383.68M
Reliance Infra RELI:IN 60.03B 7.25B
Sh Fosun Pharma 600196:CH 3B 143.64M
UPL UPLL:IN 12.77B 590M